Vanguard Group Inc Increases Stake in Ocugen Inc

The Vanguard Group Inc has filed an amendment to its Schedule 13G/A, disclosing an increased stake in Ocugen Inc. As of September 30, 2025, Vanguard holds 15,223,585 shares, representing a 4.87% ownership in the company. This marks an increase of 450,904 shares from the previous filing, with the value of the holdings rising by 65.73% to $23,748,792.60. The filing indicates that Vanguard's clients, including investment companies and managed accounts, have the right to receive dividends or proceeds from the sale of these securities. The amendment was signed by Ashley Grim, Head of Global Fund Administration, on October 31, 2025.